Cryo-Cell International Inc. (CCEL)
| Market Cap | 54.57M |
| Revenue (ttm) | 29.28M |
| Net Income (ttm) | 2.22M |
| Shares Out | 8.46M |
| EPS (ttm) | 0.27 |
| PE Ratio | 24.34 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,874 |
| Open | 6.43 |
| Previous Close | 6.45 |
| Day's Range | 6.43 - 6.51 |
| 52-Week Range | 6.00 - 14.16 |
| Beta | 0.47 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Apr 13, 2022 |
About CCEL
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technolo...
Financial Performance
In 2021, CCEL's revenue was $28.88 million, a decrease of -7.26% compared to the previous year's $31.15 million. Earnings were $2.08 million, a decrease of -42.52%.
Financial StatementsNews
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2022 Financial Results
OLDSMAR, Fla., April 13, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem ...
Cord Blood Banking Leader Cryo-Cell Announces Extravault Biorepository Service
OLDSMAR, Fla., March 16, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store st...
Cryo-Cell Shares Its 2021 Annual Letter to Shareholders
OLDSMAR, Fla., March 09, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store st...
Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2021
OLDSMAR, Fla., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store ste...
Cord Blood Banking Leader Cryo-Cell Announces Its Intent to Advance Clinical Trials
OLDSMAR, Fla., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store ste...
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2021 Financial Results
OLDSMAR, Fla., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store ste...
Cryo-Cell International Announces Changes To Its Board of Directors
MIAMI, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (Nasdaq:CCEL), the leader in cord blood and cord tissue cryopreservation services, announces the appointment of Mr. Mark Portnoy a...
Cryo-Cell International Announces Uplisting to The Nasdaq Capital Market
Cryo-Cell International, Inc. (Symbol CCEL), The Leader In Cord Blood And Cord Tissue Cryopreservation Services, Today Announced That The Company's Common Stock Has Been Approved For Listing On The Nasd...
Cryo-Cell International Completes Acquisition of Real Estate Property for Its Institute for Cellular Therapies
Cryo-Cell International (symbol: CCEL) Purchases Real Estate Location for its Institute for Cellular Therapies in the Raleigh-Durham area.
Cryo-Cell International to Present at the Q3 Virtual Investor Summit on August 18, 2021
Oldsmar, Florida--(Newsfile Corp. - August 11, 2021) - Cryo-Cell International (OTC Pink: CCEL) today announced that David Portnoy, Chairman of the board and Co-CEO will be attending the Q3 Virtual Inve...
Cryo-Cell International to Present at the Q3 Virtual Investor Summit
MIAMI, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International announces that Chairman of the Board and Co-CEO, David Portnoy, will be presenting at the Q3 Virtual Investor Summit on August 18 th , 2021.
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2021 Financial Results
OLDSMAR, Fla., July 15, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem c...
Cryo-Cell International Proudly Announces Two Ongoing COVID-19 Related Trials
MIAMI, May 10, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell's Medical Director, Dr. Joanne Kurtzberg and her research team at The Marcus Center for Cellular Cures (MC3) at Duke University School of Medicine are c...
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2021 Financial Results
OLDSMAR, Fla., April 14, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem ...